Приказ основних података о документу

dc.creatorBecarević, Mirjana
dc.creatorSeferović, Jelena
dc.creatorIgnjatović, Svetlana
dc.creatorSingh, Sandra
dc.creatorMajkić-Singh, Nada
dc.date.accessioned2019-09-02T11:30:16Z
dc.date.available2019-09-02T11:30:16Z
dc.date.issued2012
dc.identifier.issn1452-8258
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/1756
dc.description.abstractThe importance of the association of antiphospholipid antibodies (aPL Abs) with the features of type II diabetes mellitus has not yet been elucidated. The aim of this work was to investigate the association of aPL Abs with adiponectin and non-esterified fatty acids (NEFA) in type II diabetes mellitus patients without micro and/or macrovascular complications, and to analyze the differences between the male and female patients with regard to the abovementioned parameters. Male patients with type II diabetes mellitus showed a positive correlation between NEFA concentrations and anti-oxLDL antibodies (r = 0.334, p = 0.019). A weak, but statistically significant correlation between adiponectin concentrations and the IgM isotype of anti-annexin A5 antibodies was found in type II diabetes mellitus patients (r = 0.285, p = 0.011). The presence of a positive correlation between NEFA and anti-oxLDL antibodies might be useful in the detection of patients with premature atherosclerosis in type II diabetes mellitus patients without any micro and/or macrovascular complications among type II diabetes mellitus patients.en
dc.publisherDruštvo medicinskih biohemičara Srbije, Beograd i Versita
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175036/RS//
dc.rightsopenAccess
dc.sourceJournal of Medical Biochemistry
dc.subjectantiphospholipid antibodiesen
dc.subjectadiponectinen
dc.subjectdiabetes mellitus type IIen
dc.titleAdiponectin, non-esterified fatty acids and antiphospholipid antibodies in type II diabetes mellitusen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractСеферовић, Јелена; Бецаревић, Мирјана; Сингх, Сандра; Мајкић-Сингх, Нада; Игњатовић, Светлана;
dc.citation.volume31
dc.citation.issue3
dc.citation.spage199
dc.citation.epage204
dc.citation.other31(3): 199-204
dc.citation.rankM23
dc.identifier.wos000304767500005
dc.identifier.doi10.2478/v10011-012-0009-y
dc.identifier.scopus2-s2.0-84861860611
dc.identifier.fulltexthttps://farfar.pharmacy.bg.ac.rs//bitstream/id/566/1754.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу